CHI Advisors as of Sept. 30, 2023
Portfolio Holdings for CHI Advisors
CHI Advisors holds 26 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pliant Therapeutics (PLRX) | 21.4 | $55M | 3.2M | 17.34 | |
| Repare Therapeutics Ord (RPTX) | 14.3 | $36M | 3.0M | 12.08 | |
| Cullinan Oncology (CGEM) | 12.1 | $31M | 3.4M | 9.05 | |
| Acelyrin (SLRN) | 9.0 | $23M | 2.3M | 10.17 | |
| Orchard Therapeutics Spon Ads New | 5.5 | $14M | 12M | 1.14 | |
| Larimar Therapeutics (LRMR) | 5.3 | $14M | 3.4M | 3.95 | |
| Keros Therapeutics (KROS) | 5.1 | $13M | 408k | 31.88 | |
| Ikena Oncology (IKNA) | 3.7 | $9.4M | 2.2M | 4.33 | |
| Ultragenyx Pharmaceutical (RARE) | 3.0 | $7.7M | 215k | 35.65 | |
| Compass Therapeutics (CMPX) | 2.2 | $5.6M | 2.8M | 1.97 | |
| Mineralys Therapeutics (MLYS) | 2.1 | $5.4M | 568k | 9.51 | |
| Inozyme Pharma (INZY) | 2.1 | $5.3M | 1.3M | 4.20 | |
| Syros Pharmaceuticals Com New (SYRS) | 2.0 | $5.1M | 1.3M | 3.94 | |
| Blueprint Medicines (BPMC) | 1.8 | $4.7M | 93k | 50.22 | |
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 1.8 | $4.6M | 225k | 20.60 | |
| 2seventy Bio Common Stock (TSVT) | 1.5 | $3.9M | 1.0M | 3.92 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.3 | $3.4M | 60k | 57.00 | |
| Ovid Therapeutics (OVID) | 1.3 | $3.3M | 865k | 3.84 | |
| Sagimet Biosciences Com Ser A (SGMT) | 1.2 | $3.1M | 349k | 8.80 | |
| Omega Therapeutics Common Stock (OMGA) | 0.9 | $2.3M | 1.1M | 2.15 | |
| Black Diamond Therapeutics (BDTX) | 0.8 | $2.1M | 720k | 2.87 | |
| Rallybio Corp (RLYB) | 0.5 | $1.3M | 391k | 3.37 | |
| Disc Medicine (IRON) | 0.5 | $1.2M | 25k | 46.98 | |
| Graphite Bio | 0.2 | $573k | 231k | 2.48 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.1 | $373k | 87k | 4.30 | |
| Precision Biosciences Ord | 0.1 | $207k | 607k | 0.34 |
